A uterine fibroid model and its preparation method
By using a composite material design of acoustic body and self-healing repair layer, the problems of difficulty in ultrasound imaging and low reusability of uterine fibroid models are solved, providing an efficient training simulation surgical environment.
Patent Information
- Application Number
- CN202411034191.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-07-30
AI Technical Summary
Existing uterine fibroid models are difficult to visualize under ultrasound, and the repeated punctures of ablation needles result in low reusability, affecting the training efficiency of medical staff.
The design employs a composite material of an acoustic body and a repair layer. The acoustic body has acoustic impedance characteristics, and the repair layer is enclosed on the outside with self-healing properties. The acoustic body is composed of materials such as spherical aluminum powder and epoxy resin, and the repair layer is prepared by microcapsule embedding technology and has self-healing function.
A uterine fibroid model with clear imaging under ultrasound was achieved, which can be repeatedly punctured and self-repaired, improving the reliability and efficiency of training.
Smart Images

Figure CN118711448B_ABST
Abstract
Description
Technical Field
[0001] This invention patent relates to the field of medical devices, more specifically, to a human tissue model, and even more specifically, to a training model for a minimally invasive treatment technique for uterine fibroids. Background Technology
[0002] Uterine fibroids, short for uterine leiomyomas, are the most common benign tumors of the female reproductive organs. While uterine fibroids often occur without obvious symptoms, some patients may experience heavy menstrual bleeding, anemia, or pressure symptoms due to the growth of the fibroids. In more severe cases, they can lead to uterine necrosis and require hysterectomy. Therefore, even though uterine fibroids are benign tumors, they should not be underestimated, and appropriate treatment plans should be selected based on the patient's condition.
[0003] Traditional treatment methods include laparoscopic myomectomy or open myomectomy, but these surgeries involve large incisions, long recovery periods, and a high probability of complications and sequelae. With the advancement of medical technology, the concept of minimally invasive treatment has gradually permeated all aspects of surgery, promoting the application of minimally invasive surgeries such as high-frequency focused ultrasound and percutaneous microwave (radiofrequency) ablation in the treatment of benign tumors such as uterine fibroids. This can minimize the occurrence of complications such as infection and bleeding caused by open surgery.
[0004] Ultrasound ablation surgery for uterine fibroids utilizes high-frequency electromagnetic waves, composed of alternating electric and magnetic fields, to puncture the target tissue via radiofrequency ablation or a radiofrequency needle, causing coagulative necrosis and inactivation of the fibroid tissue, while causing relatively little damage to surrounding normal tissue. Because ultrasound-guided puncture requires a high level of expertise from medical personnel, and most novice doctors train by performing punctures directly on patients, repeated punctures due to lack of proficiency increase patient discomfort. Furthermore, the sensitive nature of gynecological diseases makes patients reluctant to be taught or allow novice doctors to perform procedures, reducing learning opportunities and slowing down the learning progress of medical staff in performing ultrasound ablation surgery for uterine fibroids.
[0005] Therefore, medical staff need to incorporate uterine-like models into their regular training for practicing simulated ultrasound ablation surgery for uterine fibroids. However, existing uterine models have many shortcomings: First, there are currently no uterine tumor models available that are compatible with uterine models; second, most existing uterine fibroid model materials are difficult to visualize under ultrasound; finally, using mammalian bladders, uteruses, or intestines as biomimetic uterine cavity models is cumbersome, difficult to store, and difficult to clean. Furthermore, biomimetic uterine cavity models and some ordinary silicone models have low reusability due to the need for repeated punctures with ablation needles. These difficulties make it challenging for medical trainees to use existing models for efficient and reusable simulated ultrasound ablation surgery for uterine fibroids. Summary of the Invention
[0006] To address the problems in the prior art, this invention provides a new solution, specifically involving a uterine fibroid model and its preparation method. This changes the current situation where there are no uterine tumor models available on the market that are compatible with uterine models, and solves the problems that uterine fibroid model materials are difficult to visualize under ultrasound, and that uterine fibroid models have low reusability due to the need for repeated punctures with ablation needles.
[0007] This invention is implemented through the following technical solution: a uterine fibroid model, the uterine fibroid model including an acoustic body, the acoustic body having acoustic impedance characteristics, and a repair layer enclosed around the acoustic body, the repair layer having self-healing properties; The acoustic body contains epoxy resin, aluminum powder, carboxyl-terminated nitrile butadiene rubber, silane coupling agent, and pH adjuster. The repair layer contains epoxy resin, epoxy resin monomer, purified halloysite powder (HNTs), curing catalyst, sodium alginate (SA), chitosan powder, emulsifier, glutaraldehyde crosslinking liquid, calcium chloride solution, pH adjuster, and acetone solution. The aluminum powder is sphericalized to obtain spherical aluminum powder; The spherical aluminum powder is grafted with a silane coupling agent to obtain silane-grafted aluminum powder. The microcapsules used to create the repair layer underwent at least two encapsulation processes; The chitosan crosslinked by the glutaraldehyde crosslinking solution can strongly bind to HNTs.
[0008] This invention also provides a method for preparing a uterine fibroid model, including a method for preparing an acoustic body and a repair layer, wherein the method for preparing the acoustic body includes the following steps: S1. Pretreatment: The aluminum powder is spheroidized to form a spherical structure; S2. Preparation of silane-grafted aluminum powder: The pH of a 90%–95% ethanol solution was adjusted to 4–5.2 using a pH adjuster. A silane coupling agent was added to obtain solution A. Then, 1 / 3–1 / 5 of the mass of silane spherical aluminum powder was added. The solution was heated in a water bath at 35–50°C and ultrasonically dispersed for 10–40 min to ensure uniform distribution of silane in the solution, resulting in suspension B. The suspension B was then refluxed at 70°C–130°C for 3–20 h under vacuum. Unreacted silane was removed by filtration or rinsing, and the solution was dried to obtain the silane-grafted aluminum powder product. S3. Synthesis of the acoustic body: 10-20% by mass of silane-grafted aluminum powder is dispersed in a 5-15% by volume ethanol solution and stirred to obtain mixture C. Epoxy resin is added to mixture C at 65-85℃ and ultrasonically dispersed for 10-25 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 10-20% by mass of carboxyl-terminated nitrile butadiene rubber is added until the carboxyl-terminated nitrile butadiene rubber is completely dissolved and uniformly distributed in the solution to obtain mixture D. After degassing until no bubbles are present, 0.01-5% by mass of curing catalyst is added and stirred to obtain prepolymer S. Prepolymer S is poured into a mold shaped like a uterine fibroid coated with Teflon. The uterine fibroid mold is a smooth, regularly shaped elliptical sphere with a diameter of 0.5-5 cm. The curing conditions are 80-110℃ / 2h, 100-120℃ / 1h, or 80-110℃ / 2h. After curing and cooling to room temperature, the acoustic body is obtained. The method for preparing the repair layer is specifically implemented through the following steps: S4. Preparation of capsule core material: Acetone solution and emulsifier are thoroughly mixed to obtain mixture E. A pH adjuster is added to adjust the pH value to 7-8.5. Epoxy resin monomer is uniformly dispersed and poured into mixture E. Ultrasonic dispersion for 30-150 min is used to obtain saturated emulsion F. The mass ratio of epoxy resin monomer, acetone solution and emulsifier is 9:33-40:1-2. Purified halloysite powder is then added and thoroughly mixed to obtain repair solution G. Repair solution G is transferred to a vacuum tank and evacuated with a water aspirator. After the suspension stops generating bubbles, the vacuum tank is set back to atmospheric pressure. Excess mixture is removed by centrifugation and then air-dried to obtain repair solution H. S5. Preparation of the capsule wall material: Chitosan powder was added to a 5-15% (v / v) ethanol solution to obtain a 1-2% chitosan solution. The pH of the chitosan solution was adjusted to 5.5-7 using a pH adjuster. The chitosan solution was then dispersed and poured into a glutaraldehyde crosslinking solution while stirring. S6. Core material primary embedding: Pour the repair solution H into the glutaraldehyde crosslinked chitosan solution under stirring and mix thoroughly. Transfer the mixed solution to a vacuum tank, evacuate it with a water suction device, and after the mixed solution stops generating bubbles, set the vacuum tank back to atmospheric pressure level, centrifuge to remove excess mixed solution, and then air dry to obtain repair solution I. S7. Preparation of the second layer wall material of the capsule: Purified halloysite powder was dispersed in ultrapure water and ultrasonically dispersed by magnetic stirring for 1.5-2.5 h. Then, sodium alginate powder was added to obtain a sodium alginate / haloysite mixed solution, wherein the mass ratio of sodium alginate to halloysite was 1:3-5. Calcium chloride solution was added to the sodium alginate / haloysite mixed solution to cause cross-linking reaction between sodium alginate molecules, forming the wall material solution of the microcapsules J. S8. Secondary embedding of core material: In the later stage of cross-linking of calcium chloride solution, wall material solution J is dispersed into repair solution I in droplet form and stirred at 150-800 r / min at the same time to embed epoxy resin monomers with purified halloysite powder as carrier in microcapsules. After solid-liquid separation, microcapsules are obtained by washing and drying with ultrapure water. S9. Preparation of the repair layer: The purified halloysite powder is dispersed in the epoxy resin under stirring. After stirring evenly, 5-15% by mass of microcapsules and 12-18% by mass of curing catalyst are added to the epoxy resin. The pH value is adjusted to 7-9 by adding pH adjuster to obtain prepolymer solution X. S10. Casting and processing: The obtained prepolymer liquid X is continuously cast onto the acoustic body for 18-24 hours at room temperature, so that a repair layer of 0.5-1.5 cm is formed on the outer surface of the uterine fibroid model, and further polishing is performed to form a smooth uterine fibroid model final product.
[0009] Furthermore, the epoxy resin used to manufacture the acoustic body is preferably an acrylic-modified epoxy resin; Furthermore, the silane coupling agent is one or more selected from aminopropyltrimethoxysilane, vinyltrimethoxysilane, γ-aminopropyltriethoxysilane, γ-methacryloyloxypropyltrimethoxysilane, aminopropyltriethoxysilane, and epoxypropyltrimethoxysilane. Furthermore, the epoxy resin used to make the repair layer is bisphenol A type epoxy resin, glycidyl ether type epoxy resin, or aliphatic epoxy resin, with bisphenol A type epoxy resin being preferred. Furthermore, the particle size of the purified halloysite powder (HNTs) is preferably 40–240 nm; Furthermore, the curing catalyst is an imidazole-based curing catalyst, preferably 1-ethylimidazolium (EMI), 1-methylimidazolium (MMI), 1-tert-butyl-4-methylimidazolium (TBMI), and most preferably 1-tert-butyl-4-methylimidazolium (TBMI). Furthermore, the emulsifier is preferably a polyether-type polyurethane emulsifier with epoxy end groups.
[0010] Beneficial effects: This invention, by creating a uterine fibroid composite material model with acoustic impedance and a self-healing repair layer wrapped around the outer layer of the uterine fibroid model, changes the current situation where there are no uterine tumor models on the market that are compatible with uterine models. It also solves the problems that the uterine fibroid model material is difficult to visualize under ultrasound and that the uterine fibroid model has a low reusability due to repeated punctures by ablation needles. Attached Figure Description
[0011] Figure 1 This is a flowchart of an embodiment of the present invention. Detailed Implementation
[0012] The present invention will now be described in a clear and detailed manner with reference to the accompanying drawings and embodiments. Obviously, the described embodiments are only one embodiment of the present invention and do not represent all embodiments. Other embodiments that have not been created or obtained by those skilled in the art are all within the protection scope of the present invention.
[0013] Example 1 A uterine fibroid model includes an acoustic body with acoustic impedance characteristics, and a repair layer that is enclosed on the periphery of the acoustic body and has self-healing properties. This embodiment includes a method for preparing a uterine fibroid model, wherein the method for preparing the acoustic body includes the following steps: S1. Pretreatment: High-purity aluminum powder is injected into an RF plasma torch through a feeding gun, rapidly heating the aluminum powder particles above their melting point, thus melting them and forming highly spherical droplets. These spherical droplets then rapidly cool and solidify, forming spherical aluminum powder. S2. Preparation of silane-grafted aluminum powder: The pH of a 92% ethanol solution was adjusted to 5 using a pH adjuster. Silane coupling agent KH-550 (γ-aminopropyltriethoxysilane) was added to obtain solution A. Then, spherical aluminum powder with a mass equal to that of silane was added. The solution was heated in a water bath at 45°C and ultrasonically dispersed for 30 minutes to ensure uniform distribution of silane in the solution, resulting in suspension B. Vacuum was applied, and suspension B was refluxed at 90°C for 18 hours. Unreacted silane was removed by rinsing with ultrapure water, and the solution was dried to obtain the silane-grafted aluminum powder product.
[0014] S3. Synthesis of the acoustic body: 15% by mass of silane-grafted aluminum powder is dispersed in a 10% by volume ethanol solution and stirred to obtain mixture C. At 75°C, acrylic-modified epoxy resin is added to mixture C and ultrasonically dispersed for 20 minutes to ensure that the aluminum powder is evenly distributed in the solution. After cooling to room temperature, 12% by mass of carboxyl-terminated nitrile butadiene rubber is added until the carboxyl-terminated nitrile butadiene rubber is completely dissolved and evenly distributed in the solution to obtain mixture D. After degassing until no bubbles are present, 3% by mass of 1-tert-butyl-4-methylimidazole (TBMI) is added and stirred to obtain prepolymer S. Prepolymer S is poured into a mold shaped like a uterine fibroid coated with Teflon. Preferably, the uterine fibroid mold is a smooth, regular elliptical sphere with a diameter of 3 cm. The curing conditions are 90°C / 2h + 110°C / 1h + 90°C / 2h curing and cooling to room temperature to obtain the acoustic body.
[0015] This embodiment also includes a method for preparing the repair layer, which is implemented through the following steps: S4. Preparation of capsule core material: Acetone solution and polyether polyurethane emulsifier with epoxy end groups are thoroughly mixed to obtain mixture E. A pH adjuster is added to adjust the pH value to 7.5. Bisphenol A type epoxy resin monomer is uniformly dispersed and poured into mixture E. Saturated emulsion F is obtained by ultrasonic dispersion for 120 min. The mass ratio of bisphenol A type epoxy resin monomer: acetone solution: emulsifier is 9:35:1.5. Purified halloysite powder (HNTs) is then added and thoroughly mixed to obtain repair solution G. The mixed suspension is transferred to a vacuum tank and evacuated with a water suction device. After the suspension stops generating bubbles, the vacuum tank is set back to atmospheric pressure. Excess mixed solution is removed by centrifugation and then air-dried to obtain repair solution H. S5. Preparation of the first layer of capsule wall material: Chitosan powder was added to a 10% ethanol solution to obtain a 1.5% chitosan solution. The pH of the chitosan solution was adjusted to 6 using a pH adjuster. The chitosan solution was then dispersed into a glutaraldehyde crosslinking solution while stirring. S6. Core material primary embedding: Pour the repair solution H into the glutaraldehyde crosslinked chitosan solution under stirring and mix thoroughly. Transfer the mixed solution to a vacuum tank, evacuate it with a water suction device, and after the mixed solution stops generating bubbles, set the vacuum tank back to atmospheric pressure level, centrifuge to remove excess mixed solution, and then air dry to obtain repair solution I. S7. Preparation of the second layer wall material of the capsule: Purified halloysite powder (HNTs) was dispersed in ultrapure water and ultrasonically dispersed by magnetic stirring for 2 hours. Then, sodium alginate (SA) powder was added to obtain a mixed solution of SA / HNTs, wherein the mass ratio of SA:HNTs was 1:4. Calcium chloride solution was added to the SA / HNTs mixed solution to cause cross-linking reaction between sodium alginate molecules, forming the wall material solution of the microcapsules J. S8. Secondary embedding of core material: In the later stage of cross-linking of calcium chloride solution, wall material solution J is dispersed into repair solution I in droplet form and stirred at the same time at a speed of 500 r / min, so that epoxy resin monomers with purified halloysite powder (HNTs) as carrier are embedded in microcapsules. After solid-liquid separation, the microcapsules are obtained by washing and drying with ultrapure water.
[0016] S9. Preparation of the repair layer: Purified halloysite powder (HNTs) was dispersed in a bisphenol A type epoxy resin solution under stirring. After stirring evenly, 10% by mass of microcapsules and 15% by mass of curing catalyst containing 1-tert-butyl-4-methylimidazolium (TBMI) were added to the bisphenol A type epoxy resin solution. The pH value was adjusted to 8 by adding a pH adjuster to obtain prepolymer solution X. S10. Casting and processing: The obtained prepolymer liquid X is continuously cast onto the acoustic body for 20 hours at room temperature to form a 1cm repair layer on the outer surface of the uterine fibroid model, and then further polished to form a smooth uterine fibroid model final product.
[0017] The uterine model was prepared by the following steps: 15% by weight of silane-grafted aluminum powder was dispersed in a 15% by volume ethanol solution and stirred. At 95°C, polyurethane-modified acrylate prepolymer and bisphenol A epoxy resin were added to the ethanol solution of silane-grafted aluminum powder at a mass ratio of 1:2 and ultrasonically dispersed for 30 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 15% by weight of carboxyl-terminated nitrile butadiene rubber was added until the carboxyl-terminated nitrile butadiene rubber was completely dissolved and uniformly distributed in the solution. After degassing until no bubbles were present, 5% by weight of 1-tert-butyl-4-methylimidazole (TBMI) was added and stirred to obtain printing slurry. The slurry was placed in the storage tank and automatic dispensing device of a 3D printer. After setting the printing parameters, 3D printing was performed to obtain a uterine model blank containing a cavity of uterine fibroids.
[0018] The preparation of the manipulative skin layer model is achieved through the following steps: 10% silane-grafted aluminum powder was dispersed in a 15% ethanol solution and stirred. The pH was adjusted to 4.5 with a pH adjuster. At 75°C, acrylic-modified epoxy resin and bisphenol A epoxy resin were added to the ethanol solution of silane-grafted aluminum powder at a mass ratio of 1:2 and ultrasonically dispersed for 30 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 12% carboxyl-terminated nitrile butadiene rubber was added until the carboxyl-terminated nitrile butadiene rubber was completely dissolved and uniformly distributed in the solution. After degassing until no bubbles were present, 3% 1-tert-butyl-4-methylimidazole (TBMI) was added and stirred. The slurry was poured into a square mold coated with Teflon and cured at 120°C for 1 hour. Then, it was molded under pressure of 8 MPa for 30 minutes, cured at 150°C for 2 hours, and then molded under pressure of 25 MPa for 40 minutes. After cooling to room temperature, the working skin layer model was obtained.
[0019] The following is the working process of the model created in this embodiment: 1. Insert the uterine fibroid model into the cavity of the uterine fibroid in the uterine model, place the uterine model containing the uterine fibroid model into the human body model, and cover it with the operating skin layer.
[0020] 2. Apply coupling agent to the skin layer to be operated on, start the ultrasound machine, and observe and locate the uterine fibroid under ultrasound guidance.
[0021] 3. An ablation needle is inserted into the positioned uterine model to simulate the ablation of uterine fibroids.
[0022] 4. Clean and wipe the uterine model and human model, remove the uterine fibroid model from the uterine model, observe the puncture of the repair layer, and evaluate the practice effect of ultrasound uterine fibroid ablation.
[0023] In this embodiment, by fabricating an acoustic body that is visible under ultrasound and a repair layer with self-healing ability wrapped around the acoustic body, a uterine fibroid model that can be repeatedly punctured is realized. This model, which is different from the uterine model with aluminum powder content of the acoustic body and the operation skin layer model, enables the simulation of uterine fibroid localization and ablation puncture under ultrasound guidance.
[0024] In this embodiment, acrylic modified epoxy resin, as the matrix of the acoustic impedance composite material, has high strength and hardness, which can provide a solid foundation support, effectively transmit and disperse sound waves, enhance the acoustic impedance of the composite material, and at the same time have excellent chemical and physical stability, thereby ensuring the long-term effectiveness, uniformity and consistency of acoustic impedance.
[0025] In this embodiment, the aluminum powder has a high acoustic impedance value of approximately 17 M ayl, meeting the requirements for ultrasonic reflection. Compared to the polymer matrix material, its acoustic impedance value may be more than four times higher, thus ensuring effective reflection of ultrasonic signals. The addition of aluminum powder changes the acoustic impedance value of the composite material. By adding different proportions of aluminum powder to different models, different ultrasonic images are formed by the two materials. Spheroidizing the aluminum powder can give it better flowability, high controllability, and good dispersion, resulting in excellent scattering performance and thus improving the clarity and contrast of ultrasonic imaging. Silane grafting technology can increase the number of hydroxyl groups on the surface of the aluminum powder, improving the compatibility and adhesion between the filler and the polymer. This helps reduce phonon interface scattering, improves the propagation efficiency of ultrasound in the composite material, makes ultrasonic imaging clearer and more accurate, increases the dispersibility of aluminum powder in the polymer, and extends the life of the composite material.
[0026] In this embodiment, a self-healing microcapsule encapsulates a bisphenol A type epoxy resin monomer with purified halloysite powder (HNTs) as a carrier. Utilizing the tubular structure and internal cavity of the HNTs, the repair agent can be encapsulated within the microcapsule. A vacuum method can increase the loading of the repair fluid. In the primary encapsulation, the cross-linked structure restricts the movement of chitosan segments, thereby slowing the diffusion rate of the repair fluid X. The glutaraldehyde-crosslinked nucleosan strongly binds to the purified halloysite powder (HNTs), increasing the diffusion path of the repair fluid and requiring it to overcome more obstacles to be released from the microcapsule, thus significantly delaying the release of the repair fluid X. The secondary encapsulated SA / HNTs mixed solution exhibits good chemical and thermal stability, as well as mechanical properties such as strength, hardness, and wear resistance. The two encapsulation processes synergistically increase the stability of the microcapsule. When subjected to external damage such as scratches or punctures, the release of the repair fluid can be delayed to facilitate observation of the puncture situation of the repair layer after the simulated ablation surgery. After the repair fluid is released, the bisphenol A type epoxy resin monomer can be released from the capsule and undergo a ring-opening polymerization reaction with 1-tert-butyl-4-methylimidazole (TBMI) in the matrix to complete the damage repair.
[0027] In this embodiment, the composite matrix for fabricating the uterine model is selected from polyurethane modified acrylate prepolymer and bisphenol A epoxy resin, which increases the deformation stability of the uterine model, facilitates the placement of the uterine model in the human abdominal cavity model, and can simulate uterine models in different positions, such as anteverted uterine model and retroverted uterine model, thereby enriching the scenarios for uterine fibroid ablation and puncture under different uterine conditions.
[0028] Example 2 A uterine fibroid model includes an acoustic body with acoustic impedance characteristics, and a repair layer that is enclosed on the periphery of the acoustic body and has self-healing properties. This embodiment includes a method for preparing a uterine fibroid model, wherein the method for preparing the acoustic body includes the following steps: S1. Pretreatment: High-purity aluminum powder is injected into an RF plasma torch through a feeding gun, rapidly heating the aluminum powder particles above their melting point, thus melting them and forming highly spherical droplets. These spherical droplets then rapidly cool and solidify, forming spherical aluminum powder. S2. Preparation of silane-grafted aluminum powder: The pH of a 90% ethanol solution was adjusted to 4 using a pH adjuster. KH-550 (γ-aminopropyltriethoxysilane) was added to obtain solution A. Then, spherical aluminum powder with a mass equal to that of silane was added. The solution was heated in a water bath at 35°C and ultrasonically dispersed for 10 min to ensure uniform distribution of silane in the solution, resulting in suspension B. Vacuum was applied, and suspension B was refluxed at 70°C for 3 h. Unreacted silane was removed by rinsing with ultrapure water, and the product was dried to obtain silane-grafted aluminum powder.
[0029] S3. Synthesis of the acoustic body: 10% by mass of silane-grafted aluminum powder is dispersed in a 5% by volume ethanol solution and stirred to obtain mixture C. At 65°C, acrylic-modified epoxy resin is added to mixture C and ultrasonically dispersed for 10 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 10% by mass of carboxyl-terminated nitrile butadiene rubber is added until the carboxyl-terminated nitrile butadiene rubber is completely dissolved and uniformly distributed in the solution to obtain mixture D. After degassing until no bubbles are present, 0.01% by mass of 1-tert-butyl-4-methylimidazole (TBMI) is added and stirred to obtain prepolymer S. Prepolymer S is poured into a mold shaped like a uterine fibroid coated with Teflon. Preferably, the uterine fibroid mold is a smooth, regular elliptical sphere with a diameter of 0.5 cm. The curing conditions are 80°C / 2h + 100°C / 1h + 80°C / 2h curing and cooling to room temperature to obtain the acoustic body.
[0030] This embodiment also includes a method for preparing the repair layer, which is implemented through the following steps: S4. Preparation of capsule core material: Acetone solution and polyether polyurethane emulsifier with epoxy end groups are thoroughly mixed to obtain mixture E. A pH adjuster is added to adjust the pH value to 7. Bisphenol A type epoxy resin monomer is uniformly dispersed and poured into mixture E. After ultrasonic dispersion for 30 min, a saturated emulsion F is obtained. The mass ratio of bisphenol A type epoxy resin monomer: acetone solution: emulsifier is 9:33:1. Purified halloysite powder (HNTs) is then added and thoroughly mixed to obtain repair solution G. The mixed suspension is transferred to a vacuum tank and evacuated with a water suction device. After the suspension stops generating bubbles, the vacuum tank is set back to atmospheric pressure. Excess mixed solution is removed by centrifugation and then air-dried to obtain repair solution H. S5. Preparation of the first layer of capsule wall material: Chitosan powder was added to a 5% ethanol solution to obtain a 1% chitosan solution. The pH of the chitosan solution was adjusted to 5.5 using a pH adjuster. The chitosan solution was then dispersed and poured into a glutaraldehyde crosslinking solution while stirring. S6. Core material primary embedding: Pour the repair solution H into the glutaraldehyde crosslinked chitosan solution under stirring and mix thoroughly. Transfer the mixed solution to a vacuum tank, evacuate it with a water suction device, and after the mixed solution stops generating bubbles, set the vacuum tank back to atmospheric pressure level, centrifuge to remove excess mixed solution, and then air dry to obtain repair solution I. S7. Preparation of the second layer wall material of the capsule: Purified halloysite powder (HNTs) was dispersed in ultrapure water and ultrasonically dispersed by magnetic stirring for 1.5 h. Then, sodium alginate (SA) powder was added to obtain a mixed solution of SA / HNTs, wherein the mass ratio of SA:HNTs was 1:3. Calcium chloride solution was added to the SA / HNTs mixed solution to cause cross-linking reaction between sodium alginate molecules, forming the wall material solution of the microcapsules J. S8. Secondary embedding of core material: In the later stage of cross-linking of calcium chloride solution, wall material solution J is dispersed into repair solution I in droplet form and stirred at the same time at a speed of 150 r / min, so that epoxy resin monomers with purified halloysite powder (HNTs) as carrier are embedded in microcapsules. After solid-liquid separation, the microcapsules are obtained by washing and drying with ultrapure water.
[0031] S9. Preparation of the repair layer: Purified halloysite powder (HNTs) was dispersed in a bisphenol A type epoxy resin solution under stirring. After stirring evenly, 5% by mass of microcapsules and 12% by mass of curing catalyst containing 1-tert-butyl-4-methylimidazolium (TBMI) were added to the bisphenol A type epoxy resin solution. The pH value was adjusted to 7 by adding a pH adjuster to obtain prepolymer solution X. S10. Casting and processing: The obtained prepolymer liquid X is continuously cast onto the acoustic body for 18 hours at room temperature, so that a 0.5cm repair layer is formed on the outer surface of the uterine fibroid model, and further polishing is performed to form a smooth uterine fibroid model final product.
[0032] Example 3 A uterine fibroid model includes an acoustic body with acoustic impedance characteristics, and a repair layer that is enclosed on the periphery of the acoustic body and has self-healing properties. This embodiment includes a method for preparing a uterine fibroid model, wherein the method for preparing the acoustic body includes the following steps: S1. Pretreatment: High-purity aluminum powder is injected into an RF plasma torch through a feeding gun, rapidly heating the aluminum powder particles above their melting point, thus melting them and forming highly spherical droplets. These spherical droplets then rapidly cool and solidify, forming spherical aluminum powder. S2. Preparation of silane-grafted aluminum powder: The pH of a 95% ethanol solution was adjusted to 5.2 using a pH adjuster. Silane coupling agent KH-550 (γ-aminopropyltriethoxysilane) was added to obtain solution A. Then, spherical aluminum powder with a mass equal to 1 / 5 of the silane was added. The solution was heated in a water bath at 50°C and ultrasonically dispersed for 40 minutes to ensure uniform distribution of the silane in the solution, resulting in suspension B. Vacuum was applied, and suspension B was refluxed at 130°C for 20 hours. Unreacted silane was removed by rinsing with ultrapure water, and the solution was dried to obtain the silane-grafted aluminum powder product.
[0033] S3. Synthesis of the acoustic body: 20% by mass of silane-grafted aluminum powder is dispersed in a 15% by volume ethanol solution and stirred to obtain mixture C. At 85°C, acrylic-modified epoxy resin is added to mixture C and ultrasonically dispersed for 25 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 20% by mass of carboxyl-terminated nitrile butadiene rubber is added until the carboxyl-terminated nitrile butadiene rubber is completely dissolved and uniformly distributed in the solution to obtain mixture D. After degassing until no bubbles are present, 5% by mass of a curing catalyst containing 1-tert-butyl-4-methylimidazolium (TBMI) is added and stirred to obtain prepolymer S. Prepolymer S is poured into a mold shaped like a uterine fibroid coated with Teflon. Preferably, the uterine fibroid mold is a smooth, regular elliptical sphere with a diameter of 5 cm. The curing conditions are 110°C / 2h + 120°C / 1h + 110°C / 2h, and the curing is cooled to room temperature to obtain the acoustic body.
[0034] This embodiment also includes a method for preparing the repair layer, which is implemented through the following steps: S4. Preparation of capsule core material: Acetone solution and polyether polyurethane emulsifier with epoxy end groups are thoroughly mixed to obtain mixture E. A pH adjuster is added to adjust the pH value to 8.5. Bisphenol A type epoxy resin monomer is uniformly dispersed and poured into mixture E. Saturated emulsion F is obtained by ultrasonic dispersion for 150 min. The mass ratio of bisphenol A type epoxy resin monomer: acetone solution: emulsifier is 9:40:2. Purified halloysite powder (HNTs) is then added and thoroughly mixed to obtain repair solution G. The mixed suspension is transferred to a vacuum tank and evacuated with a water suction device. After the suspension stops generating bubbles, the vacuum tank is set back to atmospheric pressure. Excess mixed solution is removed by centrifugation and then air-dried to obtain repair solution H. S5. Preparation of the first layer of capsule wall material: Chitosan powder was added to a 15% ethanol solution to obtain a 2% chitosan solution. The pH of the chitosan solution was adjusted to 7 using a pH adjuster. The chitosan solution was then dispersed and poured into a glutaraldehyde crosslinking solution while stirring. S6. Core material primary embedding: Pour the repair solution H into the glutaraldehyde crosslinked chitosan solution under stirring and mix thoroughly. Transfer the mixed solution to a vacuum tank, evacuate it with a water suction device, and after the mixed solution stops generating bubbles, set the vacuum tank back to atmospheric pressure level, centrifuge to remove excess mixed solution, and then air dry to obtain repair solution I. S7. Preparation of the second layer wall material of the capsule: Purified halloysite powder (HNTs) was dispersed in ultrapure water and ultrasonically dispersed by magnetic stirring for 2.5 h. Then, sodium alginate (SA) powder was added to obtain a mixed solution of SA / HNTs, wherein the mass ratio of SA:HNTs was 1:5. Calcium chloride solution was added to the SA / HNTs mixed solution to cause cross-linking reaction between sodium alginate molecules, forming the wall material solution of the microcapsules J. S8. Secondary embedding of core material: In the later stage of cross-linking of calcium chloride solution, wall material solution J is injected into repair solution I in droplet form and stirred at the same time at a speed of 800 r / min, so that epoxy resin monomers with purified halloysite powder (HNTs) as carrier are embedded in microcapsules. After solid-liquid separation, the microcapsules are obtained by washing and drying with ultrapure water.
[0035] S9. Preparation of the repair layer: Purified halloysite powder (HNTs) was dispersed in a bisphenol A type epoxy resin solution under stirring. After stirring evenly, 15% by mass of microcapsules and 18% by mass of curing catalyst containing 1-tert-butyl-4-methylimidazolium (TBMI) were added to the bisphenol A type epoxy resin solution. The pH value was adjusted to 9 by adding a pH adjuster to obtain prepolymer solution X. S10. Casting and Processing: The obtained prepolymer liquid X is continuously cast onto the acoustic body for 24 hours at room temperature, forming a 1.5cm repair layer on the outer surface of the uterine fibroid model. Further polishing and grinding are then performed to form a smooth-surfaced final product of the uterine fibroid model. Comparing the above examples, it can be seen that: in step S4 of Example 1, the emulsification speed is fastest when preparing emulsion F (experiments show that the emulsification speed is fastest when the pH of mixture E is 7.5); in Example 2, the material and time costs are lowest; in Example 3, the uterine fibroid model under ultrasound has the clearest boundaries, the highest clarity and contrast of ultrasound imaging, the best imaging effect, and the best self-repair layer recovery effect after acupuncture.
Claims
1. A model of uterine fibroids, characterized in that, The uterine fibroid model includes an acoustic body with acoustic impedance characteristics, and a repair layer that is enclosed on the periphery of the acoustic body and has self-healing properties. The acoustic body contains epoxy resin, aluminum powder, carboxyl-terminated nitrile butadiene rubber, silane coupling agent, and pH adjuster. The repair layer contains epoxy resin and epoxy resin monomer, purified halloysite powder, curing catalyst, sodium alginate, chitosan powder, emulsifier, glutaraldehyde crosslinking liquid, calcium chloride solution, pH adjuster, and acetone solution. The aluminum powder is sphericalized to obtain spherical aluminum powder; The spherical aluminum powder is grafted with a silane coupling agent to obtain silane-grafted aluminum powder. The microcapsules used to create the repair layer underwent at least two encapsulation processes; The chitosan crosslinked by the glutaraldehyde crosslinking solution can form a strong binding reaction with the purified halloysite powder; The method for preparing the acoustic body specifically includes the following steps: S1. Pretreatment: The aluminum powder is spheroidized to form a spherical structure; S2. Preparation of silane-grafted aluminum powder: The pH of a 90%–95% ethanol solution was adjusted to 4–5.2 using a pH adjuster. A silane coupling agent was added to obtain solution A. Then, 1 / 3–1 / 5 of the mass of silane spherical aluminum powder was added. The solution was heated in a water bath at 35–50°C and ultrasonically dispersed for 10–40 min to ensure uniform distribution of silane in the solution, resulting in suspension B. The suspension B was then refluxed at 70°C–130°C for 3–20 h under vacuum. Unreacted silane was removed by filtration or rinsing, and the solution was dried to obtain the silane-grafted aluminum powder product. S3. Synthesis of the acoustic body: 10-20% by mass of silane-grafted aluminum powder is dispersed in a 5-15% by volume ethanol solution and stirred to obtain mixture C. Epoxy resin is added to mixture C at 65-85℃ and ultrasonically dispersed for 10-25 minutes to ensure uniform distribution of aluminum powder in the solution. After cooling to room temperature, 10-20% by mass of carboxyl-terminated nitrile butadiene rubber is added until the carboxyl-terminated nitrile butadiene rubber is completely dissolved and uniformly distributed in the solution to obtain mixture D. After degassing until no bubbles are present, 0.01-5% by mass of curing catalyst is added and stirred to obtain prepolymer S. Prepolymer S is poured into a mold shaped like a uterine fibroid coated with Teflon. The uterine fibroid mold is a smooth, regularly shaped elliptical sphere with a diameter of 0.5-5 cm. The curing conditions are 80-110℃ / 2h, 100-120℃ / 1h, or 80-110℃ / 2h. After curing and cooling to room temperature, the acoustic body is obtained. The method for preparing the repair layer is specifically implemented through the following steps: S4. Preparation of capsule core material: Acetone solution and emulsifier are thoroughly mixed to obtain mixture E. A pH adjuster is added to adjust the pH value to 7-8.
5. Epoxy resin monomer is uniformly dispersed and poured into mixture E. Ultrasonic dispersion for 30-150 min is used to obtain saturated emulsion F. The mass ratio of epoxy resin monomer, acetone solution and emulsifier is 9:33-40:1-2. Purified halloysite powder is then added and thoroughly mixed to obtain repair solution G. Repair solution G is transferred to a vacuum tank and evacuated with a water aspirator. After the suspension stops generating bubbles, the vacuum tank is set back to atmospheric pressure. Excess mixture is removed by centrifugation and then air-dried to obtain repair solution H. S5. Preparation of the capsule wall material: Chitosan powder was added to a 5-15% (v / v) ethanol solution to obtain a 1-2% chitosan solution. The pH of the chitosan solution was adjusted to 5.5-7 using a pH adjuster. The chitosan solution was then dispersed and poured into a glutaraldehyde crosslinking solution while stirring. S6. Core material primary embedding: Pour the repair solution H into the glutaraldehyde crosslinked chitosan solution under stirring and mix thoroughly. Transfer the mixed solution to a vacuum tank, evacuate it with a water suction device, and after the mixed solution stops generating bubbles, set the vacuum tank back to atmospheric pressure level, centrifuge to remove excess mixed solution, and then air dry to obtain repair solution I. S7. Preparation of the second layer wall material of the capsule: Purified halloysite powder was dispersed in ultrapure water and ultrasonically dispersed by magnetic stirring for 1.5-2.5 h. Then, sodium alginate powder was added to obtain a sodium alginate / haloysite mixed solution, wherein the mass ratio of sodium alginate to halloysite was 1:3-5. Calcium chloride solution was added to the sodium alginate / haloysite mixed solution to cause cross-linking reaction between sodium alginate molecules, forming the wall material solution of the microcapsules J. S8. Secondary embedding of core material: In the later stage of cross-linking of calcium chloride solution, wall material solution J is dispersed into repair solution I in droplet form and stirred at 150-800 r / min at the same time to embed epoxy resin monomers with purified halloysite powder as carrier in microcapsules. After solid-liquid separation, microcapsules are obtained by washing and drying with ultrapure water. S9. Preparation of the repair layer: The purified halloysite powder is dispersed in the epoxy resin under stirring. After stirring evenly, 5-15% by mass of microcapsules and 12-18% by mass of curing catalyst are added to the epoxy resin. The pH value is adjusted to 7-9 by adding pH adjuster to obtain prepolymer solution X. S10. Casting and processing: The obtained prepolymer liquid X is continuously cast onto the acoustic body for 18-24 hours at room temperature, so that a repair layer of 0.5-1.5 cm is formed on the outer surface of the uterine fibroid model, and further polishing is performed to form a smooth uterine fibroid model final product.
2. The uterine fibroid model of claim 1, wherein, The epoxy resin is an acrylic-modified epoxy resin.
3. The uterine fibroid model according to claim 1, characterized in that, The silane coupling agent contains γ-aminopropyltriethoxysilane.
4. The uterine fibroid model according to claim 1, characterized in that, The epoxy resin used to make the repair layer is bisphenol A type epoxy resin.
5. The uterine fibroid model according to claim 1, characterized in that, The purified halloysite powder has a particle size of 40–240 nm.
6. The uterine fibroid model according to claim 1, characterized in that, The emulsifier is a polyether-type polyurethane emulsifier with epoxy groups at the end.
7. The uterine fibroid model according to claim 1, characterized in that, The curing catalyst is an imidazole-based curing catalyst, which contains 1-tert-butyl-4-methylimidazolium.
Citation Information
Patent Citations
Self-healing ultrasonic transmission biomimetic material
CN111808428A
Device for hysteromyoma resection operation training
CN220709831U
